Photo: Andrea Izzotti / Shutterstock.com
Three US lawmakers have introduced legislation that, if passed, would allow patent owners to obtain protection for existing biologic drugs that have been approved for new indications.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Independent Innovator and Repurposing Act, Congress, biologics, patent term extension, regulatory delay
